|
| 中医药调控Nrf2及相关通路治疗骨质疏松症研究 |
| Research on traditional Chinese medicine in regulating Nrf2 and related pathways in the treatment of osteoporosis |
| |
| DOI:10.3969/j.issn.1006-7108.2026.11.012 |
| 中文关键词: 骨质疏松症 核因子E2相关因子2 中医药 |
| 英文关键词:osteoporosis Nrf2 traditional Chinese medicine |
| 基金项目:遂宁市中医药科研专项课题重点项目(SN2024A02;SN2024A05) |
|
| 摘要点击次数: 64 |
| 全文下载次数: 0 |
| 中文摘要: |
| 随着人口老龄化程度加剧,骨质疏松症(osteoporosis, OP)的患病率逐年上升,严重威胁公众健康。核因子E2相关因子2(nuclear factor erythroid 2-related factor 2, Nrf2)是参与细胞氧化应激的关键转录因子,可通过调节成骨细胞、破骨细胞及骨细胞之间的动态平衡干预OP。中医药在OP防治中独具特色,优势显著。单味中药及其有效成分可特异性作用于Nrf2通路,调节相关基因和蛋白的表达,促进成骨、抑制破骨;中药复方通过多成分、多靶点的协同作用,整体调控 Nrf2 活性以改善骨代谢;中成药亦可作用于Nrf2通路,为 OP 治疗提供新选择。本文系统综述了中医药调控 Nrf2治疗OP的研究进展,以期为该领域的深入研究和临床应用拓宽思路并提供理论依据。 |
| 英文摘要: |
| With the aging of society, the prevalence of osteoporosis (OP) has risen year by year, posing a serious threat to public health. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor involved in cellular oxidative stress, capable of intervening in OP by regulating the dynamic equilibrium among osteoblasts, osteoclasts, and osteocytes. Traditional Chinese medicine (TCM) possesses distinctive characteristics and significant advantages in the prevention and treatment of OP. Single-flavored Chinese medicines and their active ingredients may specifically target the Nrf2 pathway, modulating the expression of related genes and proteins to promote osteogenesis and to inhibit osteoclastogenesis. TCM compound formulas exert synergistic effects through multiple components and targets, holistically regulating Nrf2 activity to improve bone metabolism. Furthermore, proprietary Chinese medicines also act upon Nrf2 pathway, offering novel therapeutic options for OP. This systematic review summarizes research progress in traditional Chinese medicine's regulation of Nrf2 for treating OP, aiming to broaden perspectives and to provide theoretical foundations for further investigation and clinical application in this field. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |